Know What Lies in the Future of Clinical Trial Management Industry

The time frame considered for the study is as follows:

• Base Year: 2016
• Forecast Period: 2017–2022

Objectives of the study are:

• To define, describe, segment, and forecast the global clinical trial management systems market by type, delivery mode, component, end user, and region
  
• To provide detailed information regarding the major factors influencing the growth of the global CTMS market (drivers, restraints, opportunities, and challenges)
  
• To strategically analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the total market
  
• To analyze the growth opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  
• To forecast the market value of market segments with respect to the four key regions, namely, North America (US, and Canada), Europe (Germany, UK, France and RoE), Asia Pacific (China, Japan, India and RoAPAC), and the Rest of the World
  
• To profile the key players in the global CTMS market and comprehensively analyze their market rank and core competencies2
  
• To track and analyze competitive developments such as product launches and enhancements; partnerships, agreements, and collaborations; mergers and acquisitions; and expansions in the global clinical trial management system market

                           Download the PDF Brochure for More Information@ http://bit.ly/2xJt7iR

The enterprise CTMS segment is estimated to account for the largest share of the CTMS market by type in 2017

The CTMS market is segmented into enterprise CTMS and site CTMS on the basis of type. The enterprise CTMS segment is expected to command the largest share of the global CTMS market in 2017, and is expected to grow at the highest CAGR in the forecast period. This is attributed to the widespread adoption of enterprise CTMS by majority of the end users.

The pharmaceutical and biopharmaceutical companies segment is expected to hold the largest share of the market in 2017

By end user, the CTMS market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, medical device companies, and others. The pharmaceutical and biopharmaceutical companies segment is further subsegmented into large pharmaceutical companies and mid-small pharmaceutical companies. The pharmaceutical and biopharmaceutical companies segment is expected to account for the largest share of the CTMS market in 2017. The largest share is attributed to the increasing adoption of CTMS software during drug clinical trials by pharmaceutical and biopharmaceutical companies.

North America is expected to dominate the CTMS market during the forecast period

Geographically, the CTMS market is segmented into North America, Europe, Asia Pacific, and the rest of the world. North America is expected to account for the largest share of the global CTMS market during the forecast period (2017-2022). Factors such as rising number of on-going clinical trials (especially in the US), presence of leading players from both demand and supply sides, and government funding for clinical research are contributing to the large share of the North American region.

The major players operating in the CTMS market include Oracle (US), Medidata Solutions (US), PAREXEL (US), Bioclinica (US), Bio-Optronics (US), and IBM (US).

Stakeholders

• Healthcare IT service providers
• Pharmaceutical/biopharmaceutical companies
• Clinical research organizations
• Research and development (R&D) companies
• Medical device companies
• Business research and consulting service providers
• Academic medical centers/universities/hospitals

      Read the Detailed Article on, "Clinical Trial Management System Market - Global Forecast to 2022", Here..!

Latest Technological Innovations are Turing Out to be a Game Changer for Global IVF Research Industry

The key factors propelling the growth of this market include growth in the median age of first-time motherhood, declining fertility rates, rising male infertility, rise in consumption of alcohol and cigarettes, and growing public awareness about infertility and the available treatment options. However, the high cost and low success rate of the IVF treatment and restrictive regulation and ethical concerns are expected to restrict the growth of market to a certain extent.

Download the PDF Brochure for More Details@ http://bit.ly/2DNf9SH

Objectives of the Study:

• To define, describe, and forecast the global in vitro fertilization market with respect to type of cycle, product, end user, and region
  
  
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
  
  
• To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
  
  
• To analyze market opportunities for stakeholders and provide details of the competitive landscape of market leaders
  
  
• To forecast the size of the global market with respect to four main regions—North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW)
  
  
• To profile the key players in the global market and comprehensively analyze their core competencies
  
  
• To track and analyze competitive developments such as agreements and partnerships, mergers, acquisitions, reprocessed medical device developments, and service launches of the leading players in the in vitro fertilization market

Reagents to account for the largest product segment in the IVF market in 2017

The product segment is classified into reagents and equipment. Reagents are further classified into cryopreservation media, semen processing media, ovum processing media, and embryo culture media. Embryo culture media is expected to hold the largest share of the IVF reagents market in 2017. This segment is also expected to grow at the highest rate during the forecast period owing to the increase in awareness of infertility treatments and diagnosis. Moreover, this media is used in IVF procedures to improve the quality of embryos during the developing phase.

Fertility clinics and surgical centers to dominate the IVF market during the forecast period

By end user, the in vitro fertilization market is segmented into fertility clinics and surgical centers, hospitals and research laboratories, and cryobanks. Fertility clinics and surgical centers are estimated to account for the largest share of the global IVF market. The increasing number of fertility centers coupled with the growing infertility rates across the globe are the key factors driving the growth of this segment.

The fresh non-donor cycle to hold the largest market share in 2017

On the basis of types of cycles, the IVF market is classified into fresh non-donor, frozen non-donor, fresh donor, and frozen donor cycles. The fresh non-donor cycle is estimated to account for the largest market share of the market in 2017. Factors such as high success rates, ease in the implantation process, and enhanced embryo production are responsible for the large share of this segment.

                 Read the Detailed Article on "In Vitro Fertilization Market - Global Forecast to 2022", Here..! 

Asia Pacific dominated the market in 2017

Asia Pacific is expected to dominate the global in vitro fertilization market in 2017. The large share and high growth rate of the APAC region can be attributed growth in the median age of first-time motherhood, rising infertility rates, growing prevalence of PCOS, increasing incidence of obesity, rise in fertility tourism, and government initiatives.

CooperSurgical (US), Vitrolife (Sweden), Cook Medical (US), Irvine Scientific (US), and Thermo Fisher Scientific (US) are the major players in the in vitro fertilization market. Other players include Esco Micro (Singapore), IVFtech (Denmark), EMD Sereno (US), Genea Limited (Australia), Rocket Medical (UK), and Nidacon International (Sweden).

Target Audience:

• In vitro fertilization manufacturers
• In vitro fertilization distributors
• Healthcare institutions (hospitals, clinics, cryobanks)
• Research institutes
• Vendors/service providers

Hospital Lighting Market: Major Growth Boosting Factors

The hospital lighting market is projected to reach USD 7.03 Billion by 2021 from USD 5.19 Billion in 2016, at a CAGR of 6.2% from 2016 to 2021.

The major factors contributing to the growth of the global hospital lighting market include the increase in adoption of LED technology, increasing size of hospitals in Europe and North America and technological enhancement will offer new opportunities during the forecast period.

                               Download the PDF Brochure for More Details@ http://bit.ly/2OSc58F

The report segments this market on the basis of product, technology, and application. On the basis of product, the market is segmented into segmented into troffers, surface-mounted lights, surgical lights and other products. In 2016, the troffer segment is expected to account for the largest share of the market due to increasing number of hospitals in Asian countries and surging adoption of LED based troffers in hospitals globally.

Based on technology, the market is segmented into segmented into fluorescent, LED, renewable energy and other technologies.  In 2016, the fluorescent segment is expected to account for the largest share of the market due to lowest cost and low operational cost. The average operational cost of a fluorescent bulb for 23 years is nearly USD 48 and the average cost per fluorescent bulb is approximately USD 2.

On the basis of applications, the market is segmented into patient wards & ICUs, examination rooms, surgical suites and other applications. The patient wards and ICUs segment is projected to witness the highest growth during the forecast period. The technical enhancements and increasing adoption of LED based fixtures in hospitals wards are the major factors driving growth of this application segment.

On the basis of geography, North America dominates the global hospital lighting market. Growth in the North American segment is primarily driven by the technological advancements, government initiatives. For example, the development of Indigo-Clean a product by Kenall Manufacturing launched in 2015, using continuous environmental disinfection technology. Indigo-Clean features technology that continuously disinfects the environment. Such a technological advancement will drive the demand for lights in hospitals.

Prominent players in this market are General Electric Company (U.S.), Acuity Brands Lighting Inc. (U.S.), Cree Inc. (U.S.), Eaton Corporation PLC (Ireland), Hubbell Incorporated (U.S.), Koninklijke Philips N.V. (Netherlands), and Zumtobel Group AG (Austria). Other players in this market include Herbert Waldmann GmbH & Co. KG (Germany), KLS Martin Group (Germany), and Trilux Lighting Ltd (U.K.).

Read the Detailed Article@ 

https://www.marketsandmarkets.com/Market-Reports/hospital-lighting-market-207496480.html

Key Questions:

• What are the business growth strategies adopted by key market players to maintain their market position across key geographies?
• What is the existing developmental pipeline of major lighting technologies among manufacturers?
• Growing adoption of LED lights procedures is a key trend in clinical management. What impact this will have on hospital lighting market during the forecast period?

Transfection Reagents and Equipment - Proposed Technological Innovations & Global Future Forecasts

The global transfection reagents market is expected to reach USD 1.02 Billion by 2021 from USD 715.4 Million in 2016, at a CAGR of 7.5% during the forecast period. 

The key factors driving the growth of this market are technology advancements in transfections, global alliances among leading research institutes to trigger drug discovery, increase in R&D spending and research activities by pharmaceutical and biotechnology companies, increase in demand for synthetic genes, and rising incidence of cancer. On the other hand, factors such as selective effectiveness of transfection reagents, home brew reagents by researchers, and high cost of transfection reagents are expected to limit the growth of the market.

Download the PDF Brochure For More Details: http://bit.ly/2Q6Hh4e

The global transfection reagents market is segmented on the basis of product, method, application, end user, and region. On the basis of product, the market is segmented into reagents and instruments. In 2016, the reagents segment is estimated to account for the largest share of the market. However, the instruments segment is expected to grow at the highest CAGR during the forecast period.

On the basis of method, the market is segmented into biochemical, physical, and viral. In 2016, the biochemical method segment is expected to command the largest share of the market. However, the viral method segment is projected to grow at the highest CAGR during the forecast period. The biochemical method segment is further divided into calcium phosphate, lipofection, DEAE-dextran, and dendrimer. In 2016, the lipofection segment is likely to account for the largest share of the market. Similarly, the physical method segment is classified into electroporation, nucleofection, and others (genegun, sonoporation, magnetofection, and optoinjection). In 2016, the electroporation segment is projected to account for the highest share of the market.

On the basis of end user, the market is segmented into academic & research institutes and pharmaceutical & biotechnologies companies. In 2016, the academic & research institutes is expected to account for the largest share of the market. However, the pharmaceutical & biotechnologies companies segment is projected to grow at the highest CAGR during the forecast period.

On the basis of application, the market is segmented into biomedical research, protein production, and therapeutic delivery. In 2016, the biomedical research segment is poised to account for the largest share of the market. However, the therapeutic delivery segment is expected to grow at the highest CAGR during the forecast period.

On the basis of region, the global transfection reagents market is segmented into North America, Europe, Asia-Pacific, and RoW. In 2016, North America is poised to account for the largest share of the market, followed by Europe and Asia-Pacific. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period and serve as a major revenue pocket for companies offering transfection reagents and equipment.

Read the Detailed Article@ 

https://www.marketsandmarkets.com/Market-Reports/transfection-reagents-equipment-market-139141146.html

Some of the major players in the global transfection reagents market include Thermo Fisher Scientific, Inc. (U.S.), Promega Corporation (U.S.), Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Polyplus-transfection SA (France), Bio-Rad Laboratories (U.S.), Lonza Group (Switzerland), Sigma-Aldrich Corporation (U.S.), Mirus Bio LLC (U.S.), and MaxCyte Inc.(U.S.).

Target Audience

• Biopharmaceutical companies
• Biotechnology companies
• Transfection equipment, reagent, and kit manufacturing companies
• Suppliers and distributors of transfection reagents
• Research institutes
• Academic centers
• Venture capitalists

Product Development and Acquisition - Key Strategies Adopted by Leading Players to Enhance Growth in the Global Tumor Ablation Market

Key Market Drivers:

# Growing Geriatric Population Across the World

# Increasing Population Base for Cancer Patients

# Technological Advancements in Ablation Devices

# Sprouting Number of Hospitals, Surgical, and Ablation Centers

Key Market Restraints:

# Cost Containment Measures Taken By Various Governments

# Ongoing Healthcare Reforms in the U.S.

Key Market Opportunities:

# Growth Potential Offered By Emerging Markets

# Growing Awareness About Ablation Procedures Over Conventional Therapeutic and Surgical Procedures

Download the PDF Brochure@

https://www.marketsandmarkets.com/pdfdownload.asp?id=142550258

The key players present in the global tumor ablation market focus on various strategies such as product approvals, launches, and enhancements; strategic acquisitions; partnerships, agreements, and collaborations; and geographic expansions in order to increase their shares in the global tumor ablation market.

During 2013-2016, product approvals, launches, and enhancements; and acquisitions were the key strategies adopted by major industry players, including AngioDynamics, Inc. (U.S.), Boston Scientific Corporation (U.S.), Galil Medical (Israel), EDAP TMS S.A. (France), HealthTronics, Inc. (U.S.), Medtronic plc (Ireland), and SonaCare Medical LLC (U.S.). Other strategies adopted by many prominent players include fund raising from private/government sources to enhance their research & development capabilities; initiatives to increase awareness about tumor ablation; and geographic expansions.

As of 2015, Medtronic plc (Ireland) held the leading position in the tumor ablation market owing to its robust product portfolio and its strong geographic presence across major markets (such as the U.S., Europe, China, Japan, Brazil, and India). The company primarily focuses on strategic acquisitions and development of technologically advanced tumor ablation systems as its key growth strategies to sustain its leadership position in the market. In line with this strategy, during 2013-2016, the company launched several tumor ablation products such as OsteoCool RF Ablation System (2016) and Barrx 360 Express radiofrequency ablation (RFA) balloon catheter (2016).

The company also adopted geographic expansion as another key growth strategy to strengthen its sales and product distribution capabilities. In line with this, Medtronic set up the Asia-Pacific regional headquarters in Singapore Singapore Health Services (SingHealth) in May 2016; SingHealth will help streamline and expand the company’s regional operations across 80 locations in Asia-Pacific.

AngioDynamics, Inc. (U.S.) held the second position in the tumor ablation market in 2015. The company has a strong product portfolio in the global tumor ablation market, including products such as Acculis MTA system, NanoKnife system, StarBurst RFA system, and UniBlate RFA electrodes. The company pursued strategic acquisitions and expansions of existing product portfolio (as well as pipeline development) as its key growth strategies. During 2013-2016, AngioDynamics acquired Microsulis Medical Ltd. (U.S.) and Navilyst Medical Inc. (U.S.); these acquisitions helped the company strengthen its market position and geographic presence. Additionally, in August 2016, AngioDynamics reported excellent clinical results with its Acculis Microwave Tissue Ablation System during cancer treatment studies (lung tumor, bone tumor, and renal tumor). This helped company to further strengthen the pipeline development for microwave ablation products.

Read the Detailed Article on "Tumor Ablation Market - Global Forecast 2021", Here..!

Care Management Solutions - Emerging Trends are Changing the Global Healthcare Industry

The key factors driving the growth of this market are the implementation of initiatives to shift the burden of risk from healthcare payers to providers, government initiatives and regulations promoting patient-centric care, initiatives to promote healthcare IT, rising geriatric population, and need to reduce healthcare costs are driving the growth of the care management solutions market.

The report describes and studies the global care management market by component, delivery mode, end user, application, and region. It provides detailed information regarding the major factors influencing the growth of this market.

Download the PDF Brochure@ 

http://bit.ly/2R1CnqG

Restraints:

Lack of Skilled Professionals

Opportunities:

# Emerging Markets

# Technological Advancements in Healthcare IT Solutions

Challenges:

# Lack of Interoperability

# High Cost of Deployment

# Data Breaches and Loss of Confidentiality

Objectives of the Study:

• To define, describe, segment, and forecast the care management solutions market by component, delivery mode, end user, application, and region
  
• To provide detailed information about factors influencing market growth (drivers, restraints, opportunities, and challenges)
  
• To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  
• To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  
• To forecast the size of the market segments with respect to North America, Europe, Asia Pacific, and the Rest of the World (RoW)
  
• To strategically analyze the market structure and profile the key players of the global care management solutions market and comprehensively analyze their core competencies
  
• To track and analyze competitive developments such as agreements, collaborations, and partnerships; product deployments; product launches, enhancements, and integrations; acquisitions; and expansions in the care management solutions market

Product deployments and launches, acquisitions, partnerships, agreements, and collaborations were strategies adopted by key players between 2015 and 2018 to enhance their share in the care management market. Important players that adopted these strategies include EXL Service Holdings, Inc. (US), Casenet, LLC (US), Medecision Inc. (US), ZeOmega Inc. (US), Cognizant Technology Solutions (US), Cerner Corporation (US), Allscripts Healthcare Solutions, Inc. (US), and TCS Healthcare Technologies (US).

The major players in the care management solutions market include EXL Service Holdings, Inc. (US), Casenet, LLC (US), Medecision Inc. (US), ZeOmega Inc. (US), Cognizant Technology Solutions (US), Cerner Corporation (US), Allscripts Healthcare Solutions, Inc. (US), and TCS Healthcare Technologies (US).

Target Audience:

• Healthcare insurance companies/payers
• Healthcare IT service providers
• Healthcare institutions/providers (hospitals, medical groups, physician practices, diagnostic centers, pharmacies, ambulatory centers, and outpatient clinics)
• Venture capitalists
• Healthcare BPO vendors
• Healthcare KPO vendors
• Government bodies
• Corporate entities
• Accountable care organizations

Read the Detailed Article on "Care Management Solutions Market - Global Forecast to 2023", Here..!

Laparoscopic and Open Hernia Mesh Repair Surgery Market worth 3.53 Billion USD by 2022

The laparoscopic surgery market is expected to reach USD 3.53 Billion by 2022 from USD 3.18 Billion in 2017, at a CAGR of 2.1% during the forecast period.

• Base Year: 2017
• Forecast Period: 2018–2022

Objectives of the Study:

• To define, describe, and forecast the hernia mesh repair surgery market, by type of surgery and type of mesh fixator (glue & tack applicator).
• To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall laparoscopic surgery market.
• To forecast the size of the market segments with respect to specific countries  
• To profile the key players and comprehensively analyze their core competencies
• To track and analyze competitive developments such as product launches; agreements, partnerships, and joint ventures; mergers and acquisitions; and research and development activities in the hernia mesh repair surgery market

Download the PDF Brochure@ https://www.marketsandmarkets.com/pdfdownload.asp?id=260433127

The laparoscopic surgery market is projected to reach USD 3.53 Billion by 2022 from USD 3.18 Billion in 2017, at a CAGR of 2.1% during the forecast period.


The increasing adoption of mesh in hernia repair surgeries, rising geriatric population, new product developments, and efficient reimbursement system in developed countries are the major factors driving the growth of the hernia mesh repair surgery market during the forecast period.

The report analyzes and studies the patient population affected with hernia in the US, Canada, Germany, France, the UK, Italy, Spain, Japan, China, and India. Along with patient population, the report studies the adoption of open and laparoscopic hernia repair surgeries and the adoption of tack and glue applicators for mesh fixation.


Based on the type of hernia repair surgery, open hernia repair surgery accounted for the largest market share in 2017. Open hernia repair does not require any advanced equipment and takes 25% lesser time than laparoscopy. This makes open hernia repair more cost effective. Moreover, this type of surgery is preferred for hernias that have been present for a long period of time.

Based on the type of mesh fixator, glue applicators are expected to register the highest growth rate in the forecast period. The cost effectiveness, reduction in surgery time, and lower pain associated with glue fixation are driving the adoption of glue in hernia mesh fixation.

The US accounted for the largest share of the hernia mesh repair surgery market in 2017. The large share of the US is attributed to the large patient population, increasing adoption of technologically advanced products, and presence of a well-established medical reimbursement policy in the country.

The major players in the hernia mesh repair surgery market profiled in this report are Medtronic (Ireland), Johnson & Johnson (US), B. Braun (Germany), C. R. Bard (US), and W.L. Gore (US).


Read the Detailed Article@ https://www.marketsandmarkets.com/Market-Reports/laparoscopic-open-hernia-mesh-repair-surgery-market-260433127.html

Global Surgical Imaging Market is Projected to Generate the Revenue worth 1.63 Billion USD by 2022

The global surgical imaging market is projected to reach USD 1.63 Billion by 2022 from an estimated value of USD 1.25 Billion in 2017, at a CAGR of 5.5%. 

The key factors driving the growth of this market are growing popularity of Flat Panel Detector C-arms (FPD C-arms) owing to advantages of FPDs over image intensifiers, reimbursement cuts on analog radiography systems, and increasing demand for minimally invasive procedures. The growing demand for data integrated imaging systems and high growth in emerging markets like Asia Pacific is an opportunity for the market to grow. However, the high cost of these instruments is restraining the growth of the global market.


Download the PDF Brochure@ https://www.marketsandmarkets.com/pdfdownload.asp?id=210534462

Objectives of the Study:

• To define, describe, and forecast the global market with respect to technology, application, and region
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
• To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze market opportunities for stakeholders and provide details of the competitive landscape of market leaders
• To forecast the size of the global market with respect to four main regions—North America, Europe, Asia Pacific, and the Rest of the World
• To profile the key players in the global market and comprehensively analyze their core competencies
• To track and analyze competitive developments such as agreements and partnerships, collaborations, acquisitions, new product launches, product approvals of the leading players.

By technology, the image intensifier C-arms segment is expected to account for the largest share of the market in 2017

On the basis of technology, the surgical imaging market is broadly segmented into image intensifier C-arms and flat panel detector C-arms (FPD C-arms). In 2017, image intensifier C-arms is expected to account for the largest share of this market owing to the huge installed base of these systems globally. Image intensifier C-arms are cheaper than FPD C-arms and hence are the preferred choice for many end users globally. Moreover, maintenance costs and services required for these C-arms are much cheaper which has made them a preferential choice.


By application, the orthopedic and trauma surgeries segment is expected to command the largest share of the market in 2017

On the basis of application, the market has been segmented into orthopedic and trauma surgeries, neurosurgeries, cardiovascular surgeries, gastrointestinal surgeries, and other applications (urology and endobronchial & thoracic surgery). The orthopedic and trauma surgeries segment is expected to command the largest share of the market in 2017. The large share and high growth of this segment can be attributed to factors such as increasing popularity of minimally invasive procedures in orthopedic and trauma surgeries and the advantage of 3D navigation with the use of C-arms.


North America to dominate the market in 2017

North America is expected to account for the largest share of the surgical imaging market in 2017, followed by Europe, Asia Pacific (APAC), and the Rest of the World. The large share of this region can be attributed to a rising number of overuse sports injuries, and rising prevalence of CVD, along with the increasing number of cardiac arrest cases, and increase in the number of minimally invasive procedures performed in Canada. However, Asia Pacific is expected to register the highest CAGR of 7.1% during the forecast period, owing to the rapid growth in geriatric population in Japan, healthcare reforms in China, improving healthcare infrastructure in India, and rising number of orthopedic and CVD procedures in Australia.


Read the Detailed Article@ https://www.marketsandmarkets.com/Market-Reports/surgical-imaging-market-210534462.html

The major players in the surgical imaging market include GE Healthcare (US), Koninklijke Philips (Netherlands), Siemens (Germany), and Ziehm Imaging (Germany).

Target Audience:

• C-arm manufacturers and distributors
• Healthcare institutions (hospitals, medical schools, group practices, individual surgeons, and governing bodies)
• Medical device vendors/service providers
• Research institutes
• Niche companies manufacturing imaging systems
• Research and consulting firms
• Venture capitalists
  

Sleep Apnea Devices - Key Strategies Adopted by Industry Leaders to Be Competent, Globally.

The sleep apnea devices market is projected to reach USD 6.49 Billion by 2023 from an estimated USD 4.44 Billion in 2018, at a CAGR of 7.8%. The sleep apnea devices market is dominated by a few players globally. Players in this market compete with each other to deliver superior quality therapeutic and diagnostic products for OSA (Obstructive Sleep Apnea). In 2017, the sleep apnea devices market was dominated by a few large players, namely, ResMed, Inc. (US), Koninklijke Philips (Netherlands), and Fisher & Paykel Healthcare Ltd. (New Zealand).

Product launches, product approvals, acquisitions, agreements, and contracts were the key strategies adopted by players between 2015 and 2018.

Download the PDF Brochure@ http://bit.ly/2QLPrQB

ResMed dominated the sleep apnea devices market in 2017. The company gained a major share in the sleep apnea devices market on account of its diversified product portfolio, widespread geographical presence, and focus on strategies such as innovation and expansions. The company strongly focuses on expansion into new product segments as well as geographies to gain a competitive edge in the market. 

Thus, to enter the high growth market, ResMed acquired Laboratoires Narval, S.A. (France) to supply custom-made mandibular advancement devices. Additionally, in February 2016, ResMed acquired Brightree LLC (US), a provider of cloud-based software solutions for the post-acute care industry. This acquisition strengthened ResMed’s market position as well as significantly expanded its software product portfolio. ResMed also has a strong patent portfolio which helps the company maintain its leadering position in the market.

Koninklijke Philips is the second largest player in the global sleep apnea devices market. The company’s strong position in this market can be attributed to its acquisition of Respironics in 2008, a US-based established manufacturer and distributor of sleep and respiratory products. The company’s wide geographical presence and strong distribution network have also helped it to gain a significant market share. 

In the past three years, innovation has been the company’s core business strategy to increase its share in the global sleep apnea devices market. This strategy is largely supported by the company’s strong R&D activities. The company invested USD 455.91 million (5.8% of its Personal Health segment sales) in R&D in 2017. The company’s rich pool of skilled R&D personnel ensures constant development and launch of technologically advanced products in the market. This further helps Philips to launch products like masks, PAP devices, and ventilators in the market.

Fisher & Paykel Healthcare accounted for the third largest share of the global sleep apnea devices market. The company strongly focuses on developing and establishing a direct sales force in major geographic markets. The company significantly invests in R&D activities to launch technologically advanced products in the market. The company’s rich pool of skilled R&D personnel ensures constant development and launch of advanced products in the market. It invested USD 59.94 million, USD 51.29 million, and USD 53.98 million in R&D in 2017, 2016, and 2015, respectively. As a result of its strong R&D activities, the company has launched sleep apnea products like nasal pillow masks, optiflow nasal cannulas, and Airspiral tubes. The growing workforce, strong R&D, and consistent new product launches are likely to help the company gain a greater market share in the coming years.

Read the Detailed Article on "Sleep Apnea Devices Market - Global Forecasts to 2023", Here..!

Other players in the sleep apnea devices market include SomnoMed Ltd. (Australia), Compumedics Limited (Australia), Löwenstein Medical GmbH & Co. KG. (Germany), Whole You, Inc. (US), BMC Medical Co., Ltd. (China), Drive DeVilbiss Healthcare (US), and Braebon Medical Corporation (Canada).

Target Audience:

• Medical devices manufacturing companies
• Medical devices suppliers and distributors
• Diagnostic laboratories
• Hospitals
• Venture capitalists
• Sleep laboratories
• Business research and consulting service providers

Global E-prescribing Industry is Rapidly Changing It's Face

Various government initiatives and incentive programs, rising focus on the reduction of fraud & abuse of controlled substances, and increasing focus on reducing medical errors, and the need to curtail escalating healthcare costs are driving the growth of the market. The increasing number of collaborations between software vendors and network providers and the vast untapped Asia-Pacific region are expected to provide significant growth opportunities for players in the market. The rising specialty prescribing, growing consolidation in the e-prescribing market, growing demand for cloud-based solution are the key trends in the market.

Restraints:

High Cost of Deployment

Reluctance to Adopt New Technology

Security and Workflow Issues

Opportunities:

Services Industry to Provide Opportunities for Revenue Generation

APAC Markets to Register High Growth

Download the PDF Brochure for More Details@ 

https://www.marketsandmarkets.com/pdfdownload.asp?id=910

Major Players And Different Strategies Adopted by Them: 

The key strategies adopted by major players in the global e-prescribing market are agreements, partnerships & collaborations; mergers & acquisitions; product launches; and geographic expansions. In this competitive market, global players aim to maintain their market position through continuous investments in R&D with a focus on developing innovative solutions or enhancing their existing solutions.

The market is consolidated at the top. Small market players operating at regional and local levels are challenging the market shares of leading players. In order to maintain their market shares, leading players are continuously signing contracts of agreements, collaborations, and partnerships. Increasing competition in this market is expected to drive innovation, thereby helping the industry to overcome the existing challenge of lack of technology awareness among end users.

Geographical Snapshot:

This report also provides market information across major regional segments, namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The e-prescribing market in Asia-Pacific is expected to register the highest growth during the forecast period owing to the healthcare organizations in the Asia-Pacific region that are actively moving towards digitization with a focus on streamlining their entire workflow and ensuring patient safety. The hospitals in Japan are widely adopting best practices, such as healthcare information exchange, e-prescribing, and electronic health record systems, to provide quality care to patients.

Target Audience

• Providers of e-prescribing systems and solutions
• E-prescribing services providers
• Hospitals & clinics
• Pharmaceuticals
• E-prescribing vendors
• Healthcare insurance providers
• Market research and consulting firms
• Venture capitalists and investors

Read the Detailed Article@ https://www.marketsandmarkets.com/Market-Reports/e-prescription-systems-market-910.html

Most-Widely Adopted Strategies in the Care Management Solutions Market, Globally..!

Care management solutions are increasingly being employed by stakeholders in the healthcare sector such as healthcare payers, providers and others (employer groups and government bodies) to achieve cost-efficiency, reduce gaps in care, and improve the quality of care delivered. The adoption of these solutions as a measure to deliver patient-centric care offers significant growth opportunities for market players in the domain of care management solutions.

The growth of the overall care management solutions market can be attributed to the implementation of initiatives to shift the burden of risk from healthcare payers to providers, initiatives to promote patient-centric care, rising geriatric population coupled with the burden of chronic diseases, need to reduce healthcare costs, growth in medical tourism sector, and advancing IT and big data capabilities. 

Download the PDF Brochure for More Details@ http://bit.ly/2QE7JmM

In the coming years, the market is expected to witness the highest growth in the European region. This is attributed to the impetus in Europe to adopt HCIT solutions to increase the efficiency of healthcare delivery, government initiatives to promote care coordination and enhance care quality, the rising aging population, and the need to curb the high cost of healthcare in Europe.

The key vendors in the global care management solutions market include Allscripts Healthcare Solutions, Inc. (U.S.), TriZetto Corporation (U.S.), Phytel Inc. (U.S.), EXL Healthcare (U.S.), AxisPoint Health (U.S.), Wellcentive, Inc. (U.S.), Medecision, Inc. (U.S.), ZeOmega Inc. (U.S.), i2i Systems, Inc. (U.S.), HealthSmart Holdings, Inc. (U.S.), Pegasystems Inc. (U.S.),  Epic Corporation Inc. (U.S.), and Harmony Information Systems, Inc. (U.S.).

These market players have implemented various growth strategies to gain a foothold and strengthen their positions in the care management solutions market. Some of the important strategies (and examples of prominent developments) adopted by market players over the last three years are listed below.

• Product Enhancement: In April 2016, EXL Healthcare launched Version 3.1 of Care Radius, its cloud-based total population health and care management platform. The solution integrates data from multiple sources to improve operational efficiency and workflows.
  
• New Product Launch: In April 2016, IBM Watson Health and behavioral health analytics provider ODH, Inc. (a subsidiary of Otsuka America, Inc.) (U.S.) launched the Mentrics platform, aimed at aiding managed care organizations that handle behavioral health benefits to deliver suitable interventions to patients with behavioral health conditions.
  
• Partnership: In February 2016, ZeOmega Inc. (U.S.) partnered with Vivify Health, Inc. (U.S.) to integrate ZeOmega’s Jiva platform with Vivify mobility applications. The partnership aimed to facilitate the management of chronic care across multiple populations, including the frail and elderly, and populations with complex co-morbidities.
  
• Acquisition: In May 2015, Phytel Inc. (U.S.) was acquired by International Business Machines (IBM) Corporation (U.S.) to strengthen its health-focused data-analytics efforts. The acquisition aims to apply advanced analytics and cognitive computing to the delivery of healthcare services to enable healthcare providers to improve the quality of care offered.

Read the Detailed Article on "Care Management Solutions Market - Analysis & Global Forecasts to 2021", Here..!

High Potency APIs: Global Industry Outlook | Different Strategies Adopted by Major Leaders

The growth in this market is driven by factors such as increasing demand for oncology drugs, growing demand for antibody-drug conjugates, increasing focus of leading pharmaceutical companies on HPAPIs, advancements in HPAPI manufacturing technologies, and growing focus on precision medicine.

Restraints:

# Requirement of Large Investments
# Discrepancies in HPAPI Banding Systems

# Uncertainties Associated With Products

# High Risk of Cross-Contamination

Opportunities:

# Growing Opportunities for CMOS and CDMOS

# Emerging Markets

Challenges:

# Need for Appropriate Process Designs

# Constant Evolution of Industry Standards and Technologies

Download the PDF Brochure for More Details@ http://bit.ly/2xmvDvb

The objectives of this study are as follows:

• To define, describe, and forecast the global HPAPI market on the basis of type, type of manufacturer, type of synthesis, therapeutic application, and region
  
  
• To provide detailed information about factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
  
  
• To strategically analyze micromarkets with respect to the individual growth trends, prospects, and contributions to the overall market
  
  
• To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  
  
• To forecast the size of the market segments of North America, Europe, Asia, and the Rest of the World (RoW)
  
  
• To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies
  
  
• To track and analyze competitive developments such as agreements, partnerships, collaborations, and alliances; mergers and acquisitions; expansions; and R&D activities in the global HPAPI market

-:Strategies Adopted by Major Leaders:-

Agreements, partnerships, collaborations, and alliances accounted for the largest share of the overall growth strategies followed by key players between 2015 and 2018.

Some of the key players in the HPAPIs market include Pfizer (US), Novartis (Switzerland), Merck (US), Teva (Israel), Mylan (US), Boehringer Ingelheim (Germany), Sanofi (France), F. Hoffmann-La Roche (Switzerland), AbbVie (US), Eli Lilly (US), Mylan (US), and Bristol-Myers Squibb (US).

Pfizer held the leading position in the HPAPIs market in 2017. The dominant position of the company can be attributed to its exhaustive product portfolio. The company has been operating in the APIs market for more than a decade and has a strong brand image, which gives it a competitive edge over other players. To remain competitive and strengthen its market position, the company primarily focuses on adopting both organic and inorganic growth strategies such as acquisitions and expansions. In 2015, Pfizer acquired Anacor Pharmaceuticals (US), a leading biopharmaceutical company and Hospira (US) a global leader in biosimilars. Such acquisitions enabled the company to expand its product offerings and global market presence.

Novartis International AG held the second position in the HPAPIs market. The company has a strong brand recognition among end users and a wide global presence. In order to maintain its leading market position, the company invests a significant amount of its revenue in R&D activities. In 2016, the company invested 18.6% of its total revenue (USD 9.0 billion) on R&D.

This significant investment enables the company to launch innovative and technologically advanced products in the market. The company also focuses on inorganic growth strategies to strengthen its position in the market. For instance, in June 2016, Novartis entered into a licensing and collaboration agreement with Xencor (US), a biopharmaceutical company that develops engineered monoclonal antibodies. The purpose of this agreement was to develop bispecific antibodies for treating cancer. Such approaches help the company to strengthen its position in the global HPAPIs market.

Read the Detailed Article on "High Potency APIs /HPAPI Market - Global Forecasts to 2023", Here..!